Importantly for our research, p14ARF is associated with anti-estrogen action whereby both mdm2 and p53 bind to the estrogen receptor (ER) and inhibit estrogen activity in breast cancer cells [9], [10], [11]. This evidence concerns the gene TP53 and breast carcinoma.